Healthcare resource use associated with the diagnosis of transthyretin amyloidosis cardiomyopathy

OBJECTIVES: Our primary aim was to evaluate the healthcare resource use associated with the diagnosis of transthyretin amyloidosis cardiomyopathy. Second, we aim to assess the effect of the number of diagnostic tests and clinical contact points on the total time and costs between symptom onset and d...

Descripción completa

Detalles Bibliográficos
Autores principales: Asher, Clint, Guilder, Andrew, Finocchiaro, Gherardo, Carr‐White, Gerry, Rodríguez‐Guadarrama, Yael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733838/
https://www.ncbi.nlm.nih.gov/pubmed/35024457
http://dx.doi.org/10.1002/hsr2.466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733838/
https://www.ncbi.nlm.nih.gov/pubmed/35024457
http://dx.doi.org/10.1002/hsr2.466

Ejemplares similares